{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:43:10Z","timestamp":1790260990482,"version":"4.1.0"},"reference-count":209,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.intimp.2024.112149","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T23:41:04Z","timestamp":1714520464000},"page":"112149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6185-466X","authenticated-orcid":false,"given":"Shumei","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4192-4897","authenticated-orcid":false,"given":"Qianjin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112149_b0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112149_b0010","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112149_b0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2017.43","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"13","author":"Morel","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112149_b0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/1756-185X.13153","article-title":"Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: a meta-analysis","volume":"20","author":"Sun","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112149_b0030","doi-asserted-by":"crossref","first-page":"e000436","DOI":"10.1136\/lupus-2020-000436","article-title":"Associations of metabolic syndrome in SLE","volume":"7","author":"Apostolopoulos","year":"2020","journal-title":"Lupus Science & Medicine"},{"key":"10.1016\/j.intimp.2024.112149_b0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.clim.2012.07.001","article-title":"Metabolic regulation of organelle homeostasis in lupus T cells","volume":"144","author":"Caza","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0040","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.cellsig.2011.05.021","article-title":"The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery","volume":"23","author":"Palmer","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2024.112149_b0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H","article-title":"Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus","volume":"46","author":"Gergely","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112149_b0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12865-020-0335-7","article-title":"Inducible nitric oxide synthase and systemic lupus erythematosus: a systematic review and meta-analysis","volume":"21","author":"Pan","year":"2020","journal-title":"BMC Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41580-021-00415-0","article-title":"The assembly, regulation and function of the mitochondrial respiratory chain","volume":"23","author":"Vercellino","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2024.112149_b0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clim.2008.07.011","article-title":"Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus","volume":"129","author":"Vyshkina","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4049\/jimmunol.1200411","article-title":"Murine lupus susceptibility locus Sle1c2 mediates CD4+ T cell activation and maps to estrogen-related receptor \u03b3","volume":"189","author":"Perry","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/gene.2009.29","article-title":"Association of UCP2 -866 G\/A polymorphism with chronic inflammatory diseases","volume":"10","author":"Yu","year":"2009","journal-title":"Genes Immun."},{"key":"10.1016\/j.intimp.2024.112149_b0075","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00018-013-1407-0","article-title":"UCP2, a mitochondrial protein regulated at multiple levels","volume":"71","author":"Donadelli","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2024.112149_b0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.freeradbiomed.2024.01.026","article-title":"Reduced mitochondrial-encoded NADH dehydrogenase 6 gene expression drives inflammatory CD4+T cells in patients with systemic lupus erythematosus","volume":"213","author":"Abdukiyum","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2024.112149_b0085","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2174\/0929867326666181126165139","article-title":"The role of mitochondria in systemic lupus erythematosus: a glimpse of various pathogenetic mechanisms","volume":"27","author":"Yang","year":"2020","journal-title":"CMC"},{"key":"10.1016\/j.intimp.2024.112149_b0090","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar3317","article-title":"Underexpression of mitochondrial-DNA encoded ATP synthesis-related genes and DNA repair genes in systemic lupus erythematosus","volume":"13","author":"Lee","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.112149_b0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/08923973.2022.2055568","article-title":"T cell metabolism and possible therapeutic targets in systemic lupus erythematosus: a narrative review","volume":"44","author":"Mu\u00f1oz-Urbano","year":"2022","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.intimp.2024.112149_b0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/ars.2013.5702","article-title":"Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus","volume":"21","author":"Doherty","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2024.112149_b0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13075-015-0542-4","article-title":"T-cell metabolism in autoimmune disease","volume":"17","author":"Yang","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.112149_b0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112149_b0115","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/art.38427","article-title":"Oxidative stress, T cell DNA methylation, and lupus","volume":"66","author":"Li","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.intimp.2024.112149_b0120","doi-asserted-by":"crossref","first-page":"21936","DOI":"10.1074\/jbc.M113.467266","volume":"288","author":"Sunahori","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.112149_b0125","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120880","article-title":"Precision DNA demethylation ameliorates disease in lupus-prone mice","volume":"3","author":"Li","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2024.112149_b0130","doi-asserted-by":"crossref","first-page":"eabq0178","DOI":"10.1126\/sciimmunol.abq0178","article-title":"Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus","volume":"8","author":"Voss","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0135","doi-asserted-by":"crossref","first-page":"e152345","DOI":"10.1172\/JCI152345","article-title":"Iron-dependent epigenetic modulation promotes pathogenic T cell differentiation in lupus","volume":"132","author":"Gao","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112149_b0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/lifemedi\/lnad021","article-title":"Cytoplasmic DNA sensing boosts CD4+ T cell metabolism for inflammatory induction","volume":"2","author":"Ye","year":"2023","journal-title":"Life Medicine"},{"key":"10.1016\/j.intimp.2024.112149_b0145","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.semarthrit.2019.04.006","article-title":"Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus","volume":"48","author":"Takeshima","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112149_b0150","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/art.41395","article-title":"Low-density neutrophils in systemic lupus erythematosus","volume":"72","author":"Tay","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.intimp.2024.112149_b0155","doi-asserted-by":"crossref","first-page":"157ra141","DOI":"10.1126\/scitranslmed.3004801","article-title":"NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus","volume":"4","author":"Campbell","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2024.112149_b0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.20151876","article-title":"Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus","volume":"213","author":"Caielli","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.112149_b0165","doi-asserted-by":"crossref","first-page":"e99238","DOI":"10.15252\/embj.201899238","article-title":"Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis","volume":"37","author":"Riley","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2024.112149_b0170","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1126\/science.aav4011","article-title":"VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease - PubMed","volume":"366","author":"Kim","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.112149_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108349","article-title":"The binding of SLE autoantibodies to mitochondria","volume":"212","author":"Pisetsky","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0180","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3389\/fimmu.2019.01026","article-title":"Autoantibodies in systemic lupus erythematosus target mitochondrial RNA","volume":"10","author":"Becker","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0185","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/BOR.0000000000000413","article-title":"Metabolic abnormalities and oxidative stress in lupus","volume":"29","author":"Lightfoot","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112149_b0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2016.04.007","article-title":"IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: regulation and underlying mechanisms","volume":"166\u2013167","author":"Rahman","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0195","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.intimp.2024.112149_b0200","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s42255-022-00711-9","article-title":"Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis","volume":"5","author":"Oaks","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.intimp.2024.112149_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103112","article-title":"mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency","volume":"140","author":"Winans","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2024.112149_b0210","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0215","doi-asserted-by":"crossref","first-page":"e104104","DOI":"10.1371\/journal.pone.0104104","article-title":"Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells","volume":"9","author":"Cao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112149_b0220","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm.3704","article-title":"De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells","volume":"20","author":"Berod","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2024.112149_b0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4049\/jimmunol.1501537","article-title":"Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus","volume":"196","author":"Yin","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0230","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112149_b0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/imr.12847","article-title":"Metabolic determinants of lupus pathogenesis","volume":"295","author":"Teng","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2024.112149_b0240","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/art.40785","article-title":"Promotion of calcium\/calmodulin-dependent protein kinase 4 by GLUT1-dependent glycolysis in systemic lupus erythematosus","volume":"71","author":"Koga","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.intimp.2024.112149_b0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/14397595.2017.1413964","article-title":"The role of CaMK4 in immune responses","volume":"28","author":"Koga","year":"2018","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112149_b0250","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI73411","article-title":"CaMK4-dependent activation of AKT\/mTOR and CREM-\u03b1 underlies autoimmunity-associated Th17 imbalance","volume":"124","author":"Koga","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112149_b0255","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/823085","article-title":"Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new","volume":"2012","author":"Alunno","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0260","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7702681","article-title":"The role of PKM2 in the regulation of mitochondrial function: focus on mitochondrial metabolism, oxidative stress, dynamic, and apoptosis PKM2 in mitochondrial function","volume":"2022","author":"Gao","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.intimp.2024.112149_b0265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumour microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0270","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112149_b0275","article-title":"Pyruvate kinase M2 contributes to TLR-mediated inflammation and autoimmunity by promoting Pyk2 activation","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0280","article-title":"Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation","volume":"e127395","author":"Kono","year":"2019","journal-title":"JCI Insight 4"},{"key":"10.1016\/j.intimp.2024.112149_b0285","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cmet.2019.10.015","article-title":"Pharmacological activation of pyruvate kinase M2 inhibits CD4+ T cell pathogenicity and suppresses autoimmunity","volume":"31","author":"Angiari","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2024.112149_b0290","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.7150\/ijbs.75434","article-title":"Lactylation of PKM2 suppresses inflammatory metabolic adaptation in pro-inflammatory macrophages","volume":"18","author":"Wang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2024.112149_b0295","doi-asserted-by":"crossref","first-page":"12993","DOI":"10.1038\/ncomms12993","article-title":"ICER is requisite for Th17 differentiation","volume":"7","author":"Yoshida","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112149_b0300","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/25785826.2022.2140503","article-title":"New insights into the metabolism of Th17 cells","volume":"46","author":"Kono","year":"2023","journal-title":"Immunol Med"},{"key":"10.1016\/j.intimp.2024.112149_b0305","doi-asserted-by":"crossref","first-page":"9288","DOI":"10.1073\/pnas.1805717115","article-title":"Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation","volume":"115","author":"Kono","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.112149_b0310","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/eji.201545760","article-title":"T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis","volume":"46","author":"Blanco","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0315","doi-asserted-by":"crossref","first-page":"e61406","DOI":"10.7554\/eLife.61406","article-title":"The kinase PDK1 is critical for promoting T follicular helper cell differentiation","volume":"10","author":"Sun","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2024.112149_b0320","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2024.112149_b0325","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/BOR.0000000000000737","article-title":"The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis","volume":"32","author":"Peclat","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112149_b0330","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.celrep.2019.12.014","article-title":"The CD38\/NAD\/SIRTUIN1\/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections","volume":"30","author":"Katsuyama","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2024.112149_b0335","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/imm.13098","article-title":"Functionally significant metabolic differences between B and T lymphocyte lineages","volume":"158","author":"Khalsa","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2024.112149_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2018.09.019","article-title":"From zero to sixty and back to zero again: the metabolic life of B cells","volume":"57","author":"Akkaya","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0345","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrrheum.2014.33","article-title":"The BAFF\/APRIL system in SLE pathogenesis","volume":"10","author":"Vincent","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112149_b0350","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","article-title":"Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells","volume":"192","author":"Caro-Maldonado","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0355","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.immuni.2016.06.011","article-title":"Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells","volume":"45","author":"Lam","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112149_b0360","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O\u2019Neill","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.112149_b0365","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.smim.2016.10.004","article-title":"Integrating immunometabolism and macrophage diversity","volume":"28","author":"Artyomov","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0370","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.112149_b0375","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/09687688.2010.495353","article-title":"High plasma membrane lipid order imaged at the immunological synapse periphery in live T cells","volume":"27","author":"Owen","year":"2010","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.intimp.2024.112149_b0380","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017394118","article-title":"LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function","volume":"118","author":"Waddington","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.112149_b0385","article-title":"Lipid metabolism: immune regulation and therapeutic prospectives in systemic lupus erythematosus","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0390","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1172\/JCI69571","article-title":"Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients","volume":"124","author":"McDonald","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112149_b0395","doi-asserted-by":"crossref","first-page":"14787","DOI":"10.1074\/jbc.M111.218610","article-title":"Lowering glycosphingolipid levels in CD4+ T cells attenuates T cell receptor signaling, cytokine production, and differentiation to the Th17 lineage","volume":"286","author":"Zhu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.112149_b0400","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nri.2016.103","article-title":"Regulation of T cell signalling by membrane lipids","volume":"16","author":"Wu","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107127","article-title":"Emerging role of Fli1 in autoimmune diseases","volume":"90","author":"He","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112149_b0410","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.4049\/jimmunol.1500961","article-title":"FLI1 levels impact CXCR3 expression and renal infiltration of T Cells and renal glycosphingolipid metabolism in the MRL\/lpr lupus mouse strain","volume":"195","author":"Sundararaj","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0415","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.654960","article-title":"Roles of BTLA in immunity and immune disorders","volume":"12","author":"Ning","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0420","doi-asserted-by":"crossref","first-page":"99711","DOI":"10.1172\/jci.insight.99711","article-title":"Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells","volume":"e99711","author":"Sawaf","year":"2018","journal-title":"JCI Insight 3"},{"key":"10.1016\/j.intimp.2024.112149_b0425","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.3390\/ijms20184505","article-title":"BTLA expression on Th1, Th2 and Th17 effector T-cells of patients with systemic lupus erythematosus is associated with active disease","volume":"20","author":"Oster","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112149_b0430","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nchembio.1714","article-title":"Sterol metabolism controls T(H)17 differentiation by generating endogenous ROR\u03b3 agonists","volume":"11","author":"Hu","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.intimp.2024.112149_b0435","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1189\/jlb.3AB0417-159RR","article-title":"Fatty acid synthase regulates the pathogenicity of Th17 cells","volume":"102","author":"Young","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2024.112149_b0440","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","article-title":"The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming","volume":"34","author":"Hochrein","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2024.112149_b0445","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3389\/fimmu.2017.01632","article-title":"Metabolism controls the balance of Th17\/T-regulatory cells","volume":"8","author":"Sun","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0450","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.4049\/jimmunol.1001437","article-title":"Peroxisome proliferator-activated receptor \u03b1 and \u03b3 agonists together with TGF-\u03b2 convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells","volume":"185","author":"Lei","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0455","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12964-022-00849-9","article-title":"The activation of PPAR\u03b3 enhances Treg responses through up-regulating CD36\/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of T\u03b2RII\/IL-2R\u03b1","volume":"20","author":"Miao","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.intimp.2024.112149_b0460","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.immuni.2015.09.007","article-title":"Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine","volume":"43","author":"Haghikia","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112149_b0465","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41590-018-0102-6","article-title":"Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27","volume":"19","author":"Ryu","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0470","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.650856","article-title":"Dietary supplementation with eicosapentaenoic acid inhibits plasma cell differentiation and attenuates lupus autoimmunity","volume":"12","author":"Kobayashi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0475","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/art.22309","article-title":"Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus","volume":"56","author":"Flores-Borja","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112149_b0480","doi-asserted-by":"crossref","unstructured":"Z. Y, G. M, W. Y, M. N, C. S, G. B, L. H, K. Ys, L. Sa, D. Sn, N. Jm, Z. K, F. D, Inositol-requiring enzyme 1\u03b1-mediated synthesis of monounsaturated fatty acids as a driver of B cell differentiation and lupus-like autoimmune disease, Arthritis & Rheumatology (Hoboken, N.J.) 73 (2021). Doi: 10.1002\/art.41883.","DOI":"10.1002\/art.41883"},{"key":"10.1016\/j.intimp.2024.112149_b0485","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4049\/jimmunol.1500291","article-title":"Fatty acid amide hydrolase regulates peripheral B Cell receptor revision, polyreactivity, and B1 cells in lupus","volume":"196","author":"Pathak","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0490","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/art.30165","article-title":"Interferon-\u03b1 priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-\u03b1 and atherosclerosis in lupus","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112149_b0495","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.immuni.2016.06.006","article-title":"Type 1 interferons induce changes in core metabolism that are critical for immune function","volume":"44","author":"Wu","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112149_b0500","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41590-021-00993-3","article-title":"Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity","volume":"22","author":"Li","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0505","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1073\/pnas.1714717115","article-title":"Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells","volume":"115","author":"Kono","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.112149_b0510","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/art.41019","article-title":"Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in MRL\/lpr mice and experimental autoimmune encephalomyelitis","volume":"71","author":"Kono","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.intimp.2024.112149_b0515","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.623844","article-title":"Amino acid metabolism in lupus","volume":"12","author":"Kono","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0520","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature23475","article-title":"Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism","volume":"548","author":"Xu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112149_b0525","doi-asserted-by":"crossref","first-page":"e36158","DOI":"10.7554\/eLife.36158","article-title":"Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation","volume":"7","author":"Lian","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2024.112149_b0530","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13063-023-07083-9","article-title":"Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: a randomized double-blind clinical trial study","volume":"24","author":"Abbasifard","year":"2023","journal-title":"Trials"},{"key":"10.1016\/j.intimp.2024.112149_b0535","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12986-018-0271-1","article-title":"Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements","volume":"15","author":"Hole\u010dek","year":"2018","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.intimp.2024.112149_b0540","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1038\/s41388-020-01480-z","article-title":"Multifaceted role of branched-chain amino acid metabolism in cancer","volume":"39","author":"Peng","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2024.112149_b0545","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.celrep.2017.10.082","article-title":"Slc3a2 Mediates branched-chain amino-acid-dependent maintenance of regulatory T cells","volume":"21","author":"Ikeda","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2024.112149_b0550","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886822","article-title":"Immunometabolism \u2013 the role of branched-chain amino acids","volume":"13","author":"Yahsi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109057","article-title":"Integration of metabolomics and lipidomics reveals serum biomarkers for systemic lupus erythematosus with different organs involvement","volume":"241","author":"Zhang","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0560","first-page":"307","article-title":"Barrier repair therapy for facial atopic eczema with a non-steroidal emollient cream containing rhamnosoft, ceramides and iso-leucine. a six-case report series","volume":"66","author":"Puviani","year":"2014","journal-title":"Minerva Pediatr"},{"key":"10.1016\/j.intimp.2024.112149_b0565","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.immuni.2019.10.001","article-title":"Amino acids license kinase mTORC1 activity and treg cell function via small G proteins Rag and Rheb","volume":"51","author":"Shi","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112149_b0570","doi-asserted-by":"crossref","first-page":"16040","DOI":"10.1038\/ncomms16040","article-title":"BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases","volume":"8","author":"Papathanassiu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112149_b0575","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2024.112149_b0580","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/rheumatology\/key398","article-title":"Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature","volume":"58","author":"Arnaud","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2024.112149_b0585","doi-asserted-by":"crossref","first-page":"e000254","DOI":"10.1136\/lupus-2017-000254","article-title":"Kynurenine pathway is altered in patients with SLE and associated with severe fatigue","volume":"5","author":"\u00c5kesson","year":"2018","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.intimp.2024.112149_b0590","doi-asserted-by":"crossref","first-page":"e0125109","DOI":"10.1371\/journal.pone.0125109","article-title":"Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus","volume":"10","author":"Lood","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112149_b0595","doi-asserted-by":"crossref","first-page":"e23522","DOI":"10.1371\/journal.pone.0023522","article-title":"Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis","volume":"6","author":"Singh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112149_b0600","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41423-020-00529-z","article-title":"Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases","volume":"18","author":"Yoshitomi","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0605","unstructured":"C. Law, V. Wacleche, Y. Cao, A. Pillai, A. Horisberger, S. Bracero, V. Skidanova, Z. Li, CXCL13+ T Cell Differentiation in systemic lupus erythematosus is controlled by opposing effects of aryl hydrocarbon receptor and type I interferon, Arthritis Rheumatol. 75 (2023). T cell metabolism and possible therapeutic targets in systemic lupus erythematosus: a narrative revi (accessed January 11, 2024)."},{"key":"10.1016\/j.intimp.2024.112149_b0610","doi-asserted-by":"crossref","first-page":"eaax2220","DOI":"10.1126\/scitranslmed.aax2220","article-title":"Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice","volume":"12","author":"Choi","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2024.112149_b0615","doi-asserted-by":"crossref","unstructured":"J. Brown, G. Abboud, L. Ma, S.-C. Choi, N. Kanda, L. Zeumer-Spataro, J. Lee, W. Peng, J. Cagmat, T. Faludi, M. Mohamadzadeh, T. Garrett, L. Mandik-Nayak, A. Chervonsky, A. Perl, L. Morel, Microbiota-mediated skewing of tryptophan catabolism modulates CD4+ Tcells in lupus-prone mice, iScience 25 (2022) 104241. Doi: 10.1016\/j.isci.2022.104241.","DOI":"10.1016\/j.isci.2022.104241"},{"key":"10.1016\/j.intimp.2024.112149_b0620","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1111\/febs.15715","article-title":"More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarization","volume":"288","author":"Kieler","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.intimp.2024.112149_b0625","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nature11540","article-title":"Serine is a natural ligand and allosteric activator of pyruvate kinase M2","volume":"491","author":"Chaneton","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112149_b0630","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cotox.2018.05.002","article-title":"mTOR\/AMPK signaling in the brain: cell metabolism, proteostasis and survival","volume":"8","author":"Garza-Lomb\u00f3","year":"2018","journal-title":"Current Opinion in Toxicology"},{"key":"10.1016\/j.intimp.2024.112149_b0635","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-pharmtox-010611-134537","article-title":"AMPK and mTOR in cellular energy homeostasis and drug targets","volume":"52","author":"Inoki","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2024.112149_b0640","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2019.09.022","article-title":"Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway","volume":"50","author":"He","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112149_b0645","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2020.01.015","article-title":"AMPK and TOR: the yin and yang of cellular nutrient sensing and growth control","volume":"31","author":"Gonz\u00e1lez","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2024.112149_b0650","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s42255-019-0157-1","article-title":"mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress","volume":"2","author":"Ling","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.intimp.2024.112149_b0655","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12014-017-9167-8","article-title":"Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay","volume":"14","author":"Petrackova","year":"2017","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.intimp.2024.112149_b0660","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41423-022-00874-1","article-title":"The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription","volume":"19","author":"Hisada","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0665","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bcp.2011.05.019","article-title":"CD3+CD4-CD8- (double negative) T cells: saviours or villains of the immune response?","volume":"82","author":"D\u2019Acquisto","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112149_b0670","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.autrev.2018.02.001","article-title":"TCR\u03b1\u03b2+CD3+CD4-CD8- (double negative) T cells in autoimmunity","volume":"17","author":"Brandt","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.112149_b0675","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.4049\/jimmunol.1301005","article-title":"Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus","volume":"191","author":"Lai","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0680","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.18632\/aging.100925","article-title":"Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL\/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway","volume":"8","author":"Gu","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.intimp.2024.112149_b0685","doi-asserted-by":"crossref","first-page":"274ra18","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2024.112149_b0690","doi-asserted-by":"crossref","first-page":"15876","DOI":"10.1038\/ncomms15876","article-title":"Lkb1 maintains Treg cell lineage identity","volume":"8","author":"Wu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112149_b0695","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1038\/s41467-024-46441-2","article-title":"Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112149_b0700","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.4049\/jimmunol.1600492","article-title":"Conditional disruption of raptor reveals an essential role for mTORC1 in B cell development, survival, and metabolism","volume":"197","author":"Iwata","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0705","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1172\/JCI86504","article-title":"mTOR has distinct functions in generating versus sustaining humoral immunity","volume":"126","author":"Jones","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112149_b0710","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/eji.201040677","article-title":"Protein synthesis in plasma cells is regulated by crosstalk between endoplasmic reticulum stress and mTOR signaling","volume":"41","author":"Goldfinger","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0715","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/annrheumdis-2019-215039","article-title":"Lupus-associated atypical memory B cells are mTORC1-hyperactivated and functionally dysregulated","volume":"78","author":"Wu","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112149_b0720","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri3383","article-title":"Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes","volume":"13","author":"Cerutti","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0725","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.immuni.2013.05.019","article-title":"The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death","volume":"39","author":"Figgett","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112149_b0730","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2172-12-7","article-title":"Autoreactive marginal zone B cells enter the follicles and interact with CD4+ T cells in lupus-prone mice","volume":"12","author":"Zhou","year":"2011","journal-title":"BMC Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0735","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/s41467-017-01602-4","article-title":"mTOR intersects antibody-inducing signals from TACI in marginal zone B cells","volume":"8","author":"Sintes","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112149_b0740","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.intimp.2016.09.017","article-title":"The role of autophagy in the pathogenesis of systemic lupus erythematosus","volume":"40","author":"Liu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112149_b0745","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2024.112149_b0750","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/ndt\/gfq496","article-title":"The PI3K\/Akt\/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin","volume":"26","author":"Stylianou","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2024.112149_b0755","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2018-213028","article-title":"Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-\u03b1 in lupus nephritis","volume":"77","author":"Qi","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112149_b0760","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1681\/ASN.2011070690","article-title":"Inhibition of MTOR disrupts autophagic flux in podocytes","volume":"23","author":"Cin\u00e0","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.intimp.2024.112149_b0765","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijcard.2014.09.035","article-title":"mTOR mediates the cross-talk of macrophage polarization and autophagy in atherosclerosis","volume":"177","author":"Tian","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.intimp.2024.112149_b0770","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12929-016-0274-z","article-title":"Autophagy is associated with cell fate in the process of macrophage-derived foam cells formation and progress","volume":"23","author":"Liu","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2024.112149_b0775","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biopha.2015.02.017","article-title":"Update on the role of autophagy in systemic lupus erythematosus: a novel therapeutic target","volume":"71","author":"Pan","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.112149_b0780","first-page":"325","article-title":"Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection","volume":"11","author":"Wu","year":"2011","journal-title":"Discov. Med."},{"key":"10.1016\/j.intimp.2024.112149_b0785","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41581-022-00587-8","article-title":"The effect of HIF on metabolism and immunity","volume":"18","author":"Taylor","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2024.112149_b0790","first-page":"1268","article-title":"Hypoxia-inducible factor-1\u03b1 and autoimmune lupus","volume":"39","author":"Yang","year":"2016","journal-title":"Arthritis Inflammation"},{"key":"10.1016\/j.intimp.2024.112149_b0795","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/eji.202048794","article-title":"Transcriptional and posttranslational regulation of Th17\/Treg balance in health and disease","volume":"51","author":"Zhang","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0800","doi-asserted-by":"crossref","first-page":"1073971","DOI":"10.3389\/fimmu.2022.1073971","article-title":"Emerging role of hypoxia-inducible factor-1\u03b1 in inflammatory autoimmune diseases: a comprehensive review","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0805","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.jfma.2022.05.003","article-title":"Increased HIF-1\u03b1 expression in T cells and associated with enhanced Th17 pathway in systemic lupus erythematosus","volume":"121","author":"Liao","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.intimp.2024.112149_b0810","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41419-021-03505-1","article-title":"The crosstalk between HIFs and mitochondrial dysfunctions in cancer development","volume":"12","author":"Bao","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2024.112149_b0815","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.molimm.2021.02.019","article-title":"HIF-1\u03b1 and miR-210 differential and lineage-specific expression in systemic lupus erythematosus","volume":"133","author":"Garchow","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0820","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/ATVBAHA.119.313290","article-title":"HIF-1\u03b1 (hypoxia-inducible factor-1\u03b1) promotes macrophage necroptosis by regulating miR-210 and miR-383","volume":"40","author":"Karshovska","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2024.112149_b0825","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112149_b0830","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/1348-0421.12168","article-title":"Effect of HIF1\u03b1 on Foxp3 expression in CD4+ CD25- T lymphocytes","volume":"58","author":"Wu","year":"2014","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0835","doi-asserted-by":"crossref","first-page":"E2784","DOI":"10.1073\/pnas.1202366109","article-title":"Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa","volume":"109","author":"Clambey","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2024.112149_b0840","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41467-022-28378-6","article-title":"In vivo CRISPR screens reveal a HIF-1\u03b1-mTOR-network regulates T follicular helper versus Th1 cells","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112149_b0845","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41590-020-0772-8","article-title":"Dynamic regulation of hypoxia-inducible factor-1\u03b1 activity is essential for normal B cell development","volume":"21","author":"Burrows","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104409","article-title":"Regulation of humoral immune response by HIF-1\u03b1-dependent metabolic reprogramming of the germinal center reaction","volume":"367","author":"Li","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0855","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41467-017-02683-x","article-title":"Hypoxia-inducible factor-1\u03b1 is a critical transcription factor for IL-10-producing B cells in autoimmune disease","volume":"9","author":"Meng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112149_b0860","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1093\/rheumatology\/kead416","article-title":"Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus","volume":"62","author":"Nepal","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2024.112149_b0865","doi-asserted-by":"crossref","first-page":"e1447","DOI":"10.1002\/cti2.1447","article-title":"Hypoxia-inducible factor-1\u03b1 regulates the interleukin-6 production by B cells in rheumatoid arthritis","volume":"12","author":"Fan","year":"2023","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.intimp.2024.112149_b0870","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203320932219","article-title":"Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression","volume":"29","author":"Mahajan","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2024.112149_b0875","doi-asserted-by":"crossref","first-page":"eaay1620","DOI":"10.1126\/scitranslmed.aay1620","article-title":"Kidney tissue hypoxia dictates T cell-mediated injury in murine lupus nephritis","volume":"12","author":"Chen","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2024.112149_b0880","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3349\/ymj.2012.53.3.587","article-title":"Urinary hypoxia-inducible factor-1alpha levels are associated with histologic chronicity changes and renal function in patients with lupus nephritis","volume":"53","author":"Ma","year":"2012","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.intimp.2024.112149_b0885","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000369564","article-title":"Hypoxia inducible factor-1 alpha promotes mesangial cell proliferation in lupus nephritis","volume":"40","author":"Deng","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.intimp.2024.112149_b0890","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s10753-018-0815-6","article-title":"RNAi Silencing of HIF-1\u03b1 Ameliorates Lupus Development in MRL\/lpr Mice","volume":"41","author":"Zhao","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2024.112149_b0895","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1080\/0886022X.2022.2072743","article-title":"Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention","volume":"44","author":"Liu","year":"2022","journal-title":"Ren. Fail."},{"key":"10.1016\/j.intimp.2024.112149_b0900","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3899\/jrheum.220089","article-title":"Cutaneous involvement in systemic lupus erythematosus: a review for the rheumatologist","volume":"50","author":"Stull","year":"2023","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112149_b0905","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13075-015-0706-2","article-title":"Pathophysiology of cutaneous lupus erythematosus","volume":"17","author":"Achtman","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.112149_b0910","doi-asserted-by":"crossref","first-page":"e166076","DOI":"10.1172\/jci.insight.166076","article-title":"HIF-1 regulates pathogenic cytotoxic T cells in lupus skin disease","volume":"8","author":"Little","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2024.112149_b0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103262","article-title":"Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus","volume":"22","author":"Erazo-Mart\u00ednez","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.112149_b0920","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","article-title":"Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE","volume":"184","author":"Caielli","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112149_b0925","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2024.112149_b0930","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11926-016-0622-8","article-title":"Activation of the mechanistic target of rapamycin in SLE: explosion of evidence in the last five years","volume":"18","author":"Oaks","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.intimp.2024.112149_b0935","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biochi.2016.04.016","article-title":"The effect of immunosuppressive molecules on T-cell metabolic reprogramming","volume":"127","author":"Fern\u00e1ndez-Ramos","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.intimp.2024.112149_b0940","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112149_b0945","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3899\/jrheum.180507","article-title":"Longterm data on sirolimus treatment in patients with lupus nephritis","volume":"45","author":"Yap","year":"2018","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112149_b0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121766","article-title":"Rapamycin-encapsulated costimulatory ICOS\/CD40L-bispecific nanoparticles restrict pathogenic helper T-B-cell interactions while in situ suppressing mTOR for lupus treatment","volume":"289","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2024.112149_b0955","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4049\/jimmunol.1801651","article-title":"Metformin Inhibits the Type 1 IFN Response in Human CD4+ T Cells","volume":"203","author":"Titov","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0960","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2019.07.001","article-title":"Metabolic regulation of pathogenic autoimmunity: therapeutic targeting","volume":"61","author":"Teng","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b0965","doi-asserted-by":"crossref","first-page":"R461","DOI":"10.1530\/ERC-14-0284","article-title":"Metformin, cancer and glucose metabolism","volume":"21","author":"Salani","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.intimp.2024.112149_b0970","first-page":"3190","article-title":"Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin, arthritis","volume":"67","author":"Wang","year":"2015","journal-title":"Rheumatol"},{"key":"10.1016\/j.intimp.2024.112149_b0975","first-page":"e210","article-title":"Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial, Lancet","volume":"2","author":"Sun","year":"2020","journal-title":"Rheumatol"},{"key":"10.1016\/j.intimp.2024.112149_b0980","first-page":"A1","article-title":"AI-03 efficacy and safety of intermittent 2-deoxyglucose therapy in mouse models of lupus","volume":"5","author":"Wilson","year":"2018","journal-title":"Lupus Sci & Med"},{"key":"10.1016\/j.intimp.2024.112149_b0985","doi-asserted-by":"crossref","unstructured":"T.J. Sproule, J. Wilson, E. Adkins, B.P. Crocker, L. Morel, D.C. Roopenian, AI-19\u2005Metabolic inhibition by 2-deoxyglucose prevents and reverses lupus in mice, Lupus Sci & Med 3 (2016) A10. Doi: 10.1136\/lupus-2016-000179.19.","DOI":"10.1136\/lupus-2016-000179.19"},{"key":"10.1016\/j.intimp.2024.112149_b0990","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.30085","article-title":"Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium\/calmodulin-dependent protein kinase type IV","volume":"63","author":"Ichinose","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112149_b0995","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1172\/JCI99507","article-title":"CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease","volume":"128","author":"Maeda","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112149_b1000","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/cr.2016.14","article-title":"Cooperative autoinhibition and multi-level activation mechanisms of calcineurin","volume":"26","author":"Li","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2024.112149_b1005","doi-asserted-by":"crossref","first-page":"e224492","DOI":"10.1001\/jamanetworkopen.2022.4492","article-title":"Effect of tacrolimus vs intravenous cyclophosphamide on complete or partial response in patients with lupus nephritis: a randomized clinical trial","volume":"5","author":"Zheng","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.intimp.2024.112149_b1010","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112149_b1015","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.reuma.2017.12.013","article-title":"Therapeutic impact of statins on the lipid profile and cardiovascular risk in patients with systemic lupus erythematosus: systematic review of the literature and a meta-analysis","volume":"15","author":"S\u00e1nchez","year":"2019","journal-title":"Reumatol. Clin. (Engl Ed)"},{"key":"10.1016\/j.intimp.2024.112149_b1020","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/ard-2022-222658","article-title":"Peroxisome proliferator activated receptor-\u03b3 agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus","volume":"81","author":"Hasni","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112149_b1025","doi-asserted-by":"crossref","first-page":"E7768","DOI":"10.1073\/pnas.1806239115","article-title":"Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling","volume":"115","author":"Hansen","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.112149_b1030","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.112149_b1035","doi-asserted-by":"crossref","first-page":"e22459","DOI":"10.1016\/j.heliyon.2023.e22459","article-title":"An overview of ATP synthase, inhibitors, and their toxicity","volume":"9","author":"Althaher","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2024.112149_b1040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2013.07.002","article-title":"The peroxisome-proliferator activated receptor-\u03b3 agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus","volume":"149","author":"Zhao","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112149_b1045","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/art.41419","article-title":"Taurine metabolism aggravates the progression of lupus by promoting the function of plasmacytoid dendritic cells","volume":"72","author":"Li","year":"2020","journal-title":"Arthritis Rheumatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T14:03:15Z","timestamp":1735308195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924006672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":209,"alternative-id":["S1567576924006672"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112149","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112149"}}